Tibet Duo Rui Pharmaceutical Co

Tibet Duo Rui Pharmaceutical Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Tibet Duo Rui Pharmaceutical Co (301075.SZ) as of Oct 11, 2026 is -94.52 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -67.18 M CNY — a change of 40.68% (lower).

EBITDA

-94.52 MCNY

YoY

40.68%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Tibet Duo Rui Pharmaceutical Co is 2025 -94.52 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Tibet Duo Rui Pharmaceutical Co was 2024 -67.18 M CNY. It decreases by 40.68% lower compared to the previous year.

The Tibet Duo Rui Pharmaceutical Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
56.43 M CNY
Jan 1, 2019
90.34 M CNY
Jan 1, 2020
114.24 M CNY
Jan 1, 2021
86.34 M CNY
Jan 1, 2022
28.69 M CNY
Jan 1, 2023
23.03 M CNY
Jan 1, 2024
-67.18 M CNY
Jan 1, 2025
-94.52 M CNY
The Tibet Duo Rui Pharmaceutical Co EBITDA history
YEAREBITDAYoY
-94.52 MCNY+40.68%
-67.18 MCNY-391.78%
23.03 MCNY-19.74%
28.69 MCNY-66.77%
86.34 MCNY-24.42%
114.24 MCNY+26.45%
90.34 MCNY+60.09%
56.43 MCNY—
Access this data via the Eulerpool API
Get Free API Key

Tibet Duo Rui Pharmaceutical Co Stock analysis

What does Tibet Duo Rui Pharmaceutical Co do? Tibet Duo Rui Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tibet Duo Rui Pharmaceutical Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Tibet Duo Rui Pharmaceutical Co is -94.52 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Tibet Duo Rui Pharmaceutical Co changed from -67.18 M CNY to -94.52 M CNY, representing a 40.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Tibet Duo Rui Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Tibet Duo Rui Pharmaceutical Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Tibet Duo Rui Pharmaceutical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Tibet Duo Rui Pharmaceutical Co